Biogen Ma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOGEN MA, and when can generic versions of BIOGEN MA drugs launch?
BIOGEN MA has one approved drug.
There are three US patents protecting BIOGEN MA drugs.
There are fifty patent family members on BIOGEN MA drugs in twenty-six countries and two supplementary protection certificates in two countries.
Summary for Biogen Ma
| International Patents: | 50 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Biogen Ma: | See patent lawsuits for Biogen Ma |
| PTAB Cases with Biogen Ma as patent owner: | See PTAB cases with Biogen Ma as patent owner |
Drugs and US Patents for Biogen Ma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | 10,968,453 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | 10,385,341 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Biogen Ma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1123288 | ⤷ Subscribe |
| Singapore | 11201608109T | ⤷ Subscribe |
| China | 111440798 | ⤷ Subscribe |
| Australia | 2022200002 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Biogen Ma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3126499 | CR 2024 00038 | Denmark | ⤷ Subscribe | PRODUCT NAME: TOFERSEN; REG. NO/DATE: EU/1/23/1783 20240603 |
| 3126499 | 301293 | Netherlands | ⤷ Subscribe | PRODUCT NAME: TOFERSEN; REGISTRATION NO/DATE: EU/1/23/1783 20240603 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
